科研之友
微信
新浪微博
Facebook
分享链接
摘要
OBJECTIVE: Acetaminophen/hydrocodone, a commonly used analgesic preparation, has been linked to rapidly progressing sensorineural hearing loss in human patients. The cellular and molecular mechanisms underlying the ototoxic effects of this drug combination are currently unknown, but are usually associated with high doses of hydrocodone. This study was aimed at identifying the specific agent responsible for hearing loss from toxic killing of cochlear sensory cells.
STUDY DESIGN: Dose-response study.
SETTING: University laboratory and private research facility.
SUBJECTS AND METHODS: Mathl green fluorescent protein neonatal mouse cochlear cultures as well as a mouse auditory cell line (HEI-OCI) were exposed in vitro to different concentrations of acetaminophen, hydromorphone (the active metabolite of hydrocodone), and the micronutrient L-carnitine, either alone or combined. Using fluorescent and light microscopy, we quantified the sensory hair cells from a 600-mu m basal segment before and after treatment. Acetaminophen/hydrocodone-induced apoptosis of HEI-OCI was evaluated by caspase 3-activation studies. Statistically significant cell survival was determined with Student t test and analysis of variance.
RESULTS: Cell death was associated mainly with exposure to acetaminophen, was slightly potentiated when combined with hydromorphone, and was partially prevented by L-carnitine. Exposure to hydrocodone or hydromorphone alone failed to kill either cochlear hair cells or HEI-OCI cells.
CONCLUSION: Our findings point to acetaminophen, rather than hydrocodone, as the primary cytotoxic agent. Hydrocodone, however, may work synergistically with acetaminophen, increasing the damage to auditory cells. These findings are an important first step toward understanding the mechanism of acetaminophen/hydrocodone ototoxicity and may lead to future treatment strategies for hearing loss from ototoxic medications.
- 出版日期2010-6
